UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of recurrent gout: Professional guidelines differ

BMJ (Online), 2008-03, Vol.336 (7642), p.463

2008

Volltextzugriff (PDF)

Discitis caused by rat bite fever in a rheumatoid arthritis patient on tocilizumab-first ever case

Rheumatology (Oxford, England), 2018-06, Vol.57 (6), p.1118-1120

2018

Volltextzugriff (PDF)

E64A Pilot Project on the Use of a Methotrexate Patient Information Film for Disease-Modifying Anti-Rheumatic Drug Counselling

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i187-i187

2016

Volltextzugriff (PDF)

186 Exeter GCA fast track pathway: 12 month results

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

Professional guidelines differ

BMJ (Online), 2008-03, Vol.336 (7642), p.463-463

2008

Volltextzugriff (PDF)

Recommendations for rheumatology ultrasound training and practice in the UK

Rheumatology (Oxford, England), 2021-06, Vol.60 (6), p.2647-2652

2021

Volltextzugriff (PDF)

105. Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Inflammatory Arthritis: A Survey of Patients Attending the Rheumatology Outpatients Department

Rheumatology (Oxford, England), 2014-04, Vol.53 (suppl_1), p.i97-i97

2014

Volltextzugriff (PDF)

Session 2: Other diseases Dietary management of osteoporosis throughout the life course

Proceedings of the Nutrition Society, 2010-02, Vol.69 (1), p.25-33

2010

Volltextzugriff (PDF)

Early life factors in the pathogenesis of osteoporosis

Current osteoporosis reports, 2009-12, Vol.7 (4), p.140-144

2009

Volltextzugriff (PDF)

Session 2: Other diseases Dietary management of osteoporosis throughout the life course: Symposium on ‘Dietary management of disease’

Proceedings of the Nutrition Society, 2010-02, Vol.69 (1), p.25-33

2010

Volltextzugriff (PDF)

The epigenetic regulation of bone mass

IBMS boneKEy, 2010-02, Vol.7 (2), p.54-62

2010

Volltextzugriff (PDF)

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (8), p.723-732

2017

Volltextzugriff (PDF)

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E1570-E1570

2012

Volltextzugriff (PDF)

4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (2), p.280-284

2006

Volltextzugriff (PDF)

DOES FOCAL LATE GADOLINIUM ENHANCEMENT AT THE RIGHT VENTRICULAR INSERTION POINTS MATTER IN RISK STRATIFICATION FOR SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY?

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1220-E1220

2013

Volltextzugriff (PDF)

Abstract 13139: Prognostic Utility of Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy: An International Multicenter Study

Circulation (New York, N.Y.), 2012-11, Vol.126 (suppl_21)

2012

Volltextzugriff (PDF)

Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2S,3R)-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland−Claisen Rearrangement

Journal of medicinal chemistry, 2003-06, Vol.46 (12), p.2275-2278

2003

Volltextzugriff (PDF)

A new series of potent benzodiazepine γ-secretase inhibitors

Bioorganic & medicinal chemistry letters, 2003-01, Vol.13 (2), p.179-183

2003

Volltextzugriff (PDF)

Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2 S ,3 R )-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy- N -((3 S )-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1 H -benzo[ e ][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland−Claisen Rearrangement

Journal of medicinal chemistry, 2003-06, Vol.46 (12), p.2275-2278

2003

Volltextzugriff (PDF)

Design and synthesis of highly potent benzodiazepine γ-secretase inhibitors: Preparation of (2S, 3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-((3S)-1-methyl-2-o xo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement

Journal of medicinal chemistry, 2003, Vol.46 (12), p.2275-2278

2003

Volltextzugriff (PDF)

A New Series of Potent Benzodiazepine γ-Secretase Inhibitors

ChemInform, 2003-05, Vol.34 (18), p.no-no

2003

Volltextzugriff (PDF)

Augustine Herrman: Beginner of the Virginia Tobacco Trade, Merchant of New Amsterdam, and First Lord of Bohemia Manor in Maryland

The Journal of Southern History, 1942, Vol.8 (3), p.414-414

Ames, Susie M.

1942

Volltextzugriff (PDF)

Hospitals

Direct Mail Fund Raising, p.27-151

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Management of recurrent gout: Professional guidelines differ

Discitis caused by rat bite fever in a rheumatoid arthritis patient on tocilizumab-first ever case

E64A Pilot Project on the Use of a Methotrexate Patient Information Film for Disease-Modifying Anti-Rheumatic Drug Counselling

186 Exeter GCA fast track pathway: 12 month results

Professional guidelines differ

Recommendations for rheumatology ultrasound training and practice in the UK

105. Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Inflammatory Arthritis: A Survey of Patients Attending the Rheumatology Outpatients Department

Session 2: Other diseases Dietary management of osteoporosis throughout the life course

Early life factors in the pathogenesis of osteoporosis

Session 2: Other diseases Dietary management of osteoporosis throughout the life course: Symposium on ‘Dietary management of disease’

The epigenetic regulation of bone mass

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

DOES FOCAL LATE GADOLINIUM ENHANCEMENT AT THE RIGHT VENTRICULAR INSERTION POINTS MATTER IN RISK STRATIFICATION FOR SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY?

Abstract 13139: Prognostic Utility of Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy: An International Multicenter Study

Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2S,3R)-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland−Claisen Rearrangement

A new series of potent benzodiazepine γ-secretase inhibitors

Design and synthesis of highly potent benzodiazepine γ-secretase inhibitors: Preparation of (2S, 3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-((3S)-1-methyl-2-o xo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement

A New Series of Potent Benzodiazepine γ-Secretase Inhibitors

Augustine Herrman: Beginner of the Virginia Tobacco Trade, Merchant of New Amsterdam, and First Lord of Bohemia Manor in Maryland

Hospitals

Suchergebnisse filtern